ClinicalTrials.gov
ClinicalTrials.gov Menu

Benefits of Upper Extremity Exercises

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02888015
Recruitment Status : Completed
First Posted : September 2, 2016
Last Update Posted : October 17, 2017
Sponsor:
Information provided by (Responsible Party):
State University of New York - Upstate Medical University

Brief Summary:
Pt will be provided with a upper extremity exercise program that will be completed daily during their session with occupational therapy. During the session the Activity Measure-Post Acute Care and an activity tolerance chart will be completed. The data from the outcome measures will be used to determine if there is a benefit to completing a daily exercise program.

Condition or disease Intervention/treatment Phase
Muscle Weakness Other: upper extremity exercise program Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Does the Use of an Upper Extremity Exercise Program Improve Activity Tolerance and Increase Independence With ADL's
Actual Study Start Date : January 2, 2017
Actual Primary Completion Date : February 13, 2017
Actual Study Completion Date : February 13, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Upper extremity exercise
Five upper extremity exercises will be provided to each of the 10 participants to complete on a daily basis. Exercises included shoulder flexion, elbow flexion/extension, shoulder abduction, internal/external rotation
Other: upper extremity exercise program
five exercises to improve upper extremity strength and endurance will be provided to patients, shoulder flexion, abduction/adduction, elbow flexion/extension, internal/external rotation
Other Name: exercise program




Primary Outcome Measures :
  1. AM PAC six clicks [ Time Frame: 6 weeks ]
    Addresses six areas of ADL's and information can be gathered by patient report , demonstration of skill or through therapeutic judgment.

  2. Activity tolerance Chart [ Time Frame: 6 weeks ]
    tracking active and inactive minutes during exercise program



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inpatient status on the medical intensive care unit
  • Current orders for occupational therapy
  • Requires moderate assist or more with 2 or more ADL's based on scores received from the Activity measures post acute assessment tool
  • Can follow multiple step commands and are alert and oriented
  • Fluent in English
  • Individuals 18 years of age and older.

Exclusion Criteria:

  • Individuals who are mechanically intubated
  • Individuals who the medical team do not feel are medically stable for therapy services
  • Individuals receiving continuous veno-venous hemofiltration.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02888015


Sponsors and Collaborators
State University of New York - Upstate Medical University
Investigators
Principal Investigator: Lori Holmes, DPT State University of New York - Upstate Medical University

Responsible Party: State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier: NCT02888015     History of Changes
Other Study ID Numbers: 889143-1
First Posted: September 2, 2016    Key Record Dates
Last Update Posted: October 17, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Muscle Weakness
Paresis
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Pathologic Processes
Signs and Symptoms